Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 2.5mg Mounjaro starting dose is delivered in approximately 0.5ml of solution. Each pre-filled KwikPen contains four weekly doses totalling around 2ml, so the 2.5mg you inject each week takes up roughly half a millilitre of that volume. Knowing this helps you understand what you're looking at in the pen window, but it doesn't change how you use it: the pen is pre-set, and the dose is fixed. Mounjaro is a prescription-only medicine, and a prescriber decides whether it is right for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you've typed "2.5mg Mounjaro in ml" into a search bar, you're probably doing one of two things: checking whether the volume you can see through the pen window looks right, or trying to work out whether anything has been used from your pen already. Both are sensible questions. A small disc of liquid visible in the cartridge window is normal and expected, the pen holds roughly 2ml in total, and your first four weekly doses of 0.5ml each will draw that down gradually.
What this search is not about, in almost every case, is needing to measure or draw up a dose yourself. The Mounjaro KwikPen is pre-filled and pre-set. You attach a needle, press the pen against your skin, and press the button. The device delivers 2.5mg (approximately 0.5ml) and stops. There is no plunger to pull, no syringe to fill, and no volume for you to calculate before injecting. If you are using a device that requires you to measure a liquid dose yourself, that is not a licensed Mounjaro KwikPen, and the standard Mounjaro 2.5mg pen format is what a regulated UK pharmacy should supply.
The right decision, then, is simply to understand what you're seeing, and to flag anything that looks genuinely unusual to your prescriber rather than adjusting anything yourself.
Mounjaro (tirzepatide) activates two gut-hormone receptors simultaneously, GIP and GLP-1, both of which are involved in appetite regulation and blood-sugar control. That dual action is also why the gastrointestinal side-effect profile (nausea, queasiness, changes in digestion) is most noticeable early in treatment. The 2.5mg starting dose is deliberately low to give your body time to adapt before the dose is increased.
In the SURMOUNT-1 trial, participants who reached higher doses saw average body-weight reductions of around 20–21% over 72 weeks, as reported in the NEJM's publication of the SURMOUNT-1 results. The 2.5mg dose was not designed to produce those outcomes on its own; it is the starting point on a titration schedule that a prescriber manages over time. Thinking of those first four weeks as an adjustment period, rather than the treatment itself, is the most accurate framing. You can read more about what happens at the step from 2.5mg to 5mg when the time comes.
The concentration of the solution in the pen is 5mg/ml for the 2.5mg pen, and if you want a closer look at how many ml 2.5mg of Mounjaro works out to and why, that breakdown explains the maths behind the fixed dose volume. Each of your four doses contains 0.5ml of a 5mg/ml solution, delivering exactly 2.5mg of tirzepatide. The pen is engineered to release that fixed volume precisely, which is also why the cartridge window will look slightly less full after each use.
The cartridge window on a new 2.5mg KwikPen should show a clear, colourless to slightly yellow solution with no particles. After your first injection, the volume visible will be noticeably less, roughly three-quarters of the original fill remains. After the second, roughly half. After the third, roughly one quarter. By the fourth injection the pen will be close to empty and should then be discarded.
If the liquid looks cloudy, discoloured or contains floating particles, do not use the pen. Contact your prescriber or pharmacist. The same applies if the pen mechanism does not click or complete the injection in the way the Patient Information Leaflet describes. For storage: Mounjaro must be refrigerated at 2–8°C; always check the Mounjaro SmPC on the eMC for the exact room-temperature window, because using a pen outside its storage conditions could affect the solution. If you're planning to travel and wondering about storage over a long weekend or a holiday, that's precisely the kind of question worth putting to your prescriber before you leave, not after you've landed.
If you have broader questions about the pen itself, the 2.5mg Mounjaro guide covers storage, injection technique and what to expect from the first four weeks in more detail.
Understanding that 2.5mg equals roughly 0.5ml is genuinely useful background knowledge. It explains why the pen window looks the way it does, and it helps you spot if something seems off. What it should not lead to is any attempt to alter, split or re-measure doses. Dose timing and titration decisions belong to the prescriber who reviewed your case, not to a calculation done at home.
If you're wondering whether your dose should change, or when a prescriber would typically move from 2.5mg to the next level, the dose-selection guidance on this topic explains how those decisions are made clinically. For context on what private treatment involves, our Mounjaro cost overview sets out what a full course of treatment typically covers. The NHS's tirzepatide information page is also a reliable plain-English reference for what the medicine is and how it works.
A prescriber at nume can review your situation and answer dose-specific questions directly. Speak to our prescribers by starting a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.